This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
28 October 2024
Fenikso Limited
("Fenikso" or "the Company")
Transaction In Own Shares
Fenikso Limited (AQSE: FNK) announces that, pursuant to the share buyback programme (the "Programme") announced on 28th October 2024, it acquired the following number of ordinary shares of
Date of purchase: |
28 October 2024 |
Number of Ordinary Shares purchased: |
10,000,000 |
Highest price paid per share (GBP): |
0.013 |
Lowest price paid per share (GBP): |
0.013 |
Volume weighted average price paid (GBP): |
0.013 |
Notification of total voting rights in accordance with paragraph 5.6.1 of the FCA's Disclosure Guidance and Transparency Rules
The purchased Ordinary Shares will be held in treasury by the Company. The issued share capital of the Company is 492,952,784 Ordinary Shares, each share carrying the right to one vote, of which 10,000,000 are held in treasury. For reporting purposes under the FCA's Disclosure and Transparency Rules the market should exclude any shares held in treasury and should use the figure 482,952,784 as denominator for the calculations by which they may determine if they are required to notify their interest in, or a change to their interest in, the Company under the Company's Memorandum and Articles of Association.
The Company will make further announcements in due course following the completion of any further purchases pursuant to the Programme.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the
The Directors of Fenikso accept responsibility for this announcement.
For further information please contact:
Fenikso Limited |
|
Thomas Richardson, Chairman |
info@feniksoplc.com |
First Sentinel Corporate Finance Limited |
|
Brian Stockbridge, Corporate Adviser |
+44 7858 888 007 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.